Leung L L, Nachman R L
J Clin Invest. 1982 Sep;70(3):542-9. doi: 10.1172/jci110646.
Using an enzyme-linked immunosorbent assay, we have demonstrated that purified human fibrinogen forms a complex with adsorbed platelet thrombospondin. The formation of the fibrinogen-thrombospondin complex was specific, saturable, and partially inhibited by mannosamine, glucosamine, and arginine. These same inhibitors have been previously shown to block thrombin-induced platelet lectin activity and platelet thrombospondin lectin activity. Adsorbed thrombospondin also formed a complex with fibronectin, although the extent of complex formation was significantly less than the extent of formation of the fibrinogen-thrombospondin complex. Platelet membrane glycoproteins IIb and IIIa, which have been previously shown to bind fibrinogen, did not inhibit the formation of the fibrinogen-thrombospondin complex. The present study supports the hypothesis that the interaction of fibrinogen with thrombospondin on the activated platelet surface may be an important step in the platelet aggregation process.
利用酶联免疫吸附测定法,我们已经证明纯化的人纤维蛋白原与吸附的血小板凝血酶敏感蛋白形成复合物。纤维蛋白原 - 凝血酶敏感蛋白复合物的形成具有特异性、可饱和性,并且被甘露糖胺、葡糖胺和精氨酸部分抑制。这些相同的抑制剂先前已被证明可阻断凝血酶诱导的血小板凝集素活性和血小板凝血酶敏感蛋白凝集素活性。吸附的凝血酶敏感蛋白也与纤连蛋白形成复合物,尽管复合物形成的程度明显小于纤维蛋白原 - 凝血酶敏感蛋白复合物的形成程度。先前已证明可结合纤维蛋白原的血小板膜糖蛋白IIb和IIIa并不抑制纤维蛋白原 - 凝血酶敏感蛋白复合物的形成。本研究支持这样的假说,即纤维蛋白原与活化血小板表面上的凝血酶敏感蛋白之间的相互作用可能是血小板聚集过程中的一个重要步骤。